Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4021586

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4021586
CYTOKINETICS (NASDAQ: CYTK) Delayed: 74.12 +2.19 (3.04%)
Previous Close $71.93    52 Week High $13.18 
Open $73.55    52 Week Low $6.00 
Day High $74.17    P/E N/A 
Day Low $71.41    EPS $-1.24 
Volume 601,566